EAM

Exome Asset Management Portfolio holdings

AUM $110M
1-Year Est. Return 24.83%
This Quarter Est. Return
1 Year Est. Return
+24.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$112M
AUM Growth
-$21.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1 +$4.73M
2 +$3.72M
3 +$2.93M
4
RGNX icon
Regenxbio
RGNX
+$2.9M
5
DYN icon
Dyne Therapeutics
DYN
+$2.7M

Top Sells

1 +$4.58M
2 +$4.46M
3 +$3.81M
4
BMY icon
Bristol-Myers Squibb
BMY
+$3.69M
5
BSX icon
Boston Scientific
BSX
+$3.62M

Sector Composition

1 Healthcare 98.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$10.6B
$5.72M 5.09%
165,496
-81,204
GH icon
2
Guardant Health
GH
$8.67B
$5.42M 4.82%
127,182
-20,618
GERN icon
3
Geron
GERN
$798M
$5.11M 4.54%
3,215,457
+1,654,305
AZN icon
4
AstraZeneca
AZN
$258B
$4.73M 4.2%
+32,534
CYTK icon
5
Cytokinetics
CYTK
$6.97B
$4.16M 3.7%
103,483
+37,600
SNDX icon
6
Syndax Pharmaceuticals
SNDX
$1.34B
$4.14M 3.68%
337,198
+18,298
IONS icon
7
Ionis Pharmaceuticals
IONS
$11.5B
$4.09M 3.64%
135,616
+74,249
LLY icon
8
Eli Lilly
LLY
$722B
$3.86M 3.43%
4,673
-3,574
COGT icon
9
Cogent Biosciences
COGT
$2.35B
$3.72M 3.31%
+621,678
ISRG icon
10
Intuitive Surgical
ISRG
$164B
$3.15M 2.8%
6,358
-1,069
SLNO icon
11
Soleno Therapeutics
SLNO
$3.43B
$3.1M 2.76%
43,441
-33,844
AKRO icon
12
Akero Therapeutics
AKRO
$4.32B
$3.09M 2.75%
76,379
+7,771
IRON icon
13
Disc Medicine
IRON
$3.02B
$3.06M 2.72%
61,656
-7,416
VRDN icon
14
Viridian Therapeutics
VRDN
$2B
$2.93M 2.6%
+217,294
RGNX icon
15
Regenxbio
RGNX
$627M
$2.9M 2.58%
+405,281
REPL icon
16
Replimune Group
REPL
$646M
$2.87M 2.56%
294,846
+240,108
SRRK icon
17
Scholar Rock
SRRK
$2.71B
$2.71M 2.41%
84,339
+6,900
DYN icon
18
Dyne Therapeutics
DYN
$2.4B
$2.7M 2.4%
+258,391
NTRA icon
19
Natera
NTRA
$25.6B
$2.64M 2.34%
18,650
-3,800
ETNB icon
20
89bio
ETNB
$2.2B
$2.57M 2.29%
353,882
+128,559
PEN icon
21
Penumbra
PEN
$9.67B
$2.41M 2.14%
9,000
SVRA icon
22
Savara
SVRA
$697M
$2.32M 2.06%
836,397
+136,699
ANAB icon
23
AnaptysBio
ANAB
$989M
$2.17M 1.93%
+116,623
TVTX icon
24
Travere Therapeutics
TVTX
$2.42B
$2.11M 1.88%
+118,017
CNTA
25
Centessa Pharmaceuticals
CNTA
$3.06B
$2.05M 1.82%
142,744
+5,028